Bariatrics/GI clinical trial - Celgene

Bariatrics

Gastroenterology

Status:

active and enrolling

ClinicalTrials.gov:

NCT03467958

Celgene 3204 - RPCO1-3202

Drug

Ozanimod

Phase

III

Condition

Crohn Disease